Cargando…
Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
Autores principales: | Centonze, Matteo, Di Conza, Giusy, Lahn, Michael, Fabregat, Isabel, Dituri, Francesco, Gigante, Isabella, Serino, Grazia, Scialpi, Rosanna, Carrieri, Livianna, Negro, Roberto, Pizzuto, Elena, Giannelli, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436453/ https://www.ncbi.nlm.nih.gov/pubmed/37596687 http://dx.doi.org/10.1186/s13046-023-02797-9 |
Ejemplares similares
-
Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
por: Centonze, Matteo, et al.
Publicado: (2023) -
Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors
por: Deken, M.A., et al.
Publicado: (2023) -
Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not
por: Tang, Xiaoyun, et al.
Publicado: (2023) -
Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma
por: Dituri, Francesco, et al.
Publicado: (2022) -
Laminin-332 γ2 Monomeric Chain Promotes Adhesion and Migration of Hepatocellular Carcinoma Cells
por: Scialpi, Rosanna, et al.
Publicado: (2023)